News & Events

NACHGEFRAGT: "Vaccination: important and right?"


Christoph Rademacher, Professor of Molecular Drug Targeting at the University of Vienna, is researching new methods that can be used to vaccinate more efficiently and painlessly. He and Günther Mayr, head of ORF's science editorial department, discuss this new technology, how vaccines work in the body, what vaccines have brought to mankind and much more.

The online conversation will be streamed live on YouTube and will take place in cooperation with APA Science - Austria's platform for education, science and research.

Questions about the topic can be asked in advance on the social media channels using #fraguniwien.

Christoph Rademacher has held the professorship of Molecular Drug Targeting at the University of Vienna since September 2020. He is researching innovative vaccination techniques that are completely painless and many times more efficient - also against Sars-CoV-2. "My team and I, we are looking for new ways at the molecular level to ensure that active substances only act on those cells where they are actually supposed to go. This will allow us to minimize side effects and increase efficiency," Rademacher said. In the new process, vaccines will enter the body via very specific immune cells in the skin - administered painlessly with a patch - and trigger immunization from there. This means that up to 20 times more people can probably be vaccinated with the same number of doses as with the conventional method.

Christoph Rademacher received a Starting Grant from the European Research Council in 2016 for his promising research and led a research group at the Max Planck Institute of Colloids and Interfaces in Potsdam until 2020. Since September 2020, Rademacher has been Professor of Molecular Drug Targeting at the Faculty of Life Sciences at the University of Vienna. His research focuses include work on new therapies through targeted drug delivery to cells of the immune system.


NACHGEFRAGT "Vaccination: why is it important and right?"
Tuesday, February 23, 4:00-5:00 p.m.
Livestream on


The event will be available for review as a webstream.